Verve Therapeutics (VERV) News Today $11.00 -0.03 (-0.23%) As of 02:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook (VERV)Goldman Sachs raised its year-end S&P 500 forecast and identified three stocks that are poised to outperform in the second half of 2025: KSS, NTLA, and GOGO.July 15 at 4:27 PM | marketbeat.comBiotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.July 14 at 12:44 PM | msn.comBiotech Stocks Are Ready to Rebound. 3 to Watch Now.July 14 at 2:41 AM | msn.comExperimental treatment for high cholesterol edits DNA in the body to reduce LDLJuly 11, 2025 | msn.comVerve Therapeutics Inc News (VERV) - Investing.comJuly 4, 2025 | investing.comVerve Therapeutics, Inc. (NASDAQ:VERV) Given Average Recommendation of "Hold" by AnalystsJuly 3, 2025 | marketbeat.comBMO Capital Markets Downgrades Verve Therapeutics (NASDAQ:VERV) to HoldJune 28, 2025 | marketbeat.comBMO Capital Markets Reiterates Market Perform Rating for Verve Therapeutics (NASDAQ:VERV)June 27, 2025 | marketbeat.comVERV Verve Therapeutics, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comGAMMA Investing LLC Acquires 27,485 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV)June 24, 2025 | marketbeat.comLilly To Acquire Verve For One-Time Cardiovascular TreatmentsJune 23, 2025 | insidermonkey.comWhy Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This WeekJune 20, 2025 | fool.com$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Verve Therapeutics, Inc. (NASDAQ: VERV)June 20, 2025 | globenewswire.comQ2 Earnings Forecast for VERV Issued By Lifesci CapitalJune 19, 2025 | marketbeat.comVerve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3BJune 19, 2025 | msn.comVERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERVJune 18, 2025 | businesswire.comVerve Therapeutics (NASDAQ:VERV) Receives Neutral Rating from HC WainwrightJune 18, 2025 | marketbeat.comLifesci Capital Reaffirms "Market Perform" Rating for Verve Therapeutics (NASDAQ:VERV)June 18, 2025 | marketbeat.comVerve Therapeutics' (VERV) "Hold" Rating Reiterated at Jefferies Financial GroupJune 18, 2025 | marketbeat.comLock In The 81.5% Run - Initiating Verve With A SellJune 18, 2025 | seekingalpha.comVerve Therapeutics (NASDAQ:VERV) Sets New 12-Month High - Here's WhyJune 18, 2025 | marketbeat.comThese Stocks Are Moving the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and MoreJune 17, 2025 | msn.comLilly to Buy Gene-Editing Partner Verve for up to $1.3 Billion in Cardiac Care PushJune 17, 2025 | money.usnews.comEli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bnJune 17, 2025 | finance.yahoo.comEli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugsJune 17, 2025 | msn.comThese Stocks Moved the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, Tesla, T-Mobile, Jabil, and MoreJune 17, 2025 | msn.comVerve Therapeutics Target of Unusually Large Options Trading (NASDAQ:VERV)June 17, 2025 | marketbeat.comThese Stocks Are Moving the Most Today: Sunrun, Enphase, Verve Therapeutics, Palantir, T-Mobile, Lennar, Jabil, and MoreJune 17, 2025 | msn.comVerve Therapeutics (NASDAQ:VERV) Shares Gap Up - Here's What HappenedJune 17, 2025 | marketbeat.comWhy Verve Therapeutics Stock Is Skyrocketing TodayJune 17, 2025 | fool.comVERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to ShareholdersJune 17, 2025 | businesswire.comVerve Therapeutics' (VERV) Market Perform Rating Reiterated at William BlairJune 17, 2025 | marketbeat.comVerve Therapeutics (NASDAQ:VERV) Earns Hold Rating from Canaccord Genuity GroupJune 17, 2025 | marketbeat.comVerve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly TakeoverJune 17, 2025 | investors.comShareholder Alert: The Ademi Firm Investigates Whether Verve Therapeutics, Inc. Is Obtaining a Fair Price for Its Public ShareholdersJune 17, 2025 | businesswire.comEli Lilly to Acquire Verve Therapeutics for Up to $1.3 BillionJune 17, 2025 | wsj.comGreen energy stocks stumble, and other early market moversJune 17, 2025 | marketwatch.comEli Lilly strikes $1.3 billion deal to buy gene-editing biotech Verve Therapeutics, companies sayJune 17, 2025 | msn.comEli Lilly to acquire gene-editing therapy developer Verve Therapeutics for up to $1.3 billion, companies sayJune 17, 2025 | reuters.comLilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular riskJune 17, 2025 | prnewswire.comEli Lilly Close to $1.3 Billion Bid for Biotech, Says Report. Verve Therapeutics Stock Soars 80%.June 17, 2025 | barrons.comEli Lilly close to buying gene-editing biotech Verve TherapeuticsJune 17, 2025 | ft.comVerve Therapeutics Soars 75% After-Hours Following Report Of $1.3B Eli Lilly Takeover TalksJune 17, 2025 | msn.comEli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reportsJune 16, 2025 | reuters.comVerve Therapeutics’ SWOT analysis: gene editing stock shows promise amid challengesJune 15, 2025 | investing.comVerve Therapeutics (NASDAQ:VERV) Shares Gap Down - Should You Sell?June 13, 2025 | marketbeat.comVerve Therapeutics reports voting results from annual meetingJune 11, 2025 | investing.comVerve Therapeutics (NASDAQ:VERV) Shares Gap Up - What's Next?June 9, 2025 | marketbeat.comVerve Therapeutics, Inc. (NASDAQ:VERV) Given Consensus Rating of "Buy" by AnalystsJune 8, 2025 | marketbeat.comVerve Therapeutics (NASDAQ:VERV) Trading 10.1% Higher - Time to Buy?June 5, 2025 | marketbeat.com Get Verve Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERV and its competitors with MarketBeat's FREE daily newsletter. Email Address VERV Media Mentions By Week VERV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERV News Sentiment▼0.550.96▲Average Medical News Sentiment VERV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERV Articles This Week▼57▲VERV Articles Average Week Get Verve Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VERV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Beam Therapeutics News Today PTC Therapeutics News Today Arcellx News Today Merus News Today Zai Lab News Today Scholar Rock News Today ACADIA Pharmaceuticals News Today Viking Therapeutics News Today SpringWorks Therapeutics News Today Protagonist Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VERV) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VERV Stock Alerts